clinical / clinicalCardio-Oncology

Alexander Lyon

亚历山大·里昂

MD, PhD, FRCP

🏢Royal Brompton Hospital, Imperial College London(皇家布朗普顿医院，伦敦帝国理工学院)🌐UK

Professor of Cardio-Oncology; Consultant Cardiologist心脏肿瘤学教授；心脏病学顾问医师

h-index

Key Papers

Awards

Key Contributions

👥Biography 个人简介

Europe's foremost cardio-oncologist, based at the Royal Brompton Hospital and Imperial College London. Professor Lyon has led the development of ESC cardio-oncology guidelines and is globally recognized for his research on immune checkpoint inhibitor myocarditis and cardiovascular toxicity of modern cancer therapies.

🧪Research Fields 研究领域

ICI-Associated Myocarditis免疫检查点抑制剂相关心肌炎

Cardio-Oncology European Guidelines心脏肿瘤学欧洲指南

Checkpoint Inhibitor Cardiovascular Toxicity免疫检查点抑制剂心血管毒性

🎓Key Contributions 主要贡献

ESC Cardio-Oncology Guidelines

Chaired and led the European Society of Cardiology 2022 Cardio-Oncology Guidelines, providing the most comprehensive global evidence-based framework for cardiovascular care of cancer patients.

ICI Myocarditis

Made seminal contributions to understanding the clinical presentation, diagnosis, and management of immune checkpoint inhibitor-associated myocarditis, including cardiac MRI diagnostic protocols.

Representative Works 代表性著作

[1]

2022 ESC Guidelines on Cardio-Oncology

European Heart Journal (2022)

Landmark ESC guidelines providing comprehensive evidence-based recommendations for cardiovascular management across all cancer therapy types.

[2]

Diagnosis and Management of ICI-Associated Myocarditis

European Heart Journal (2021)

Expert consensus document establishing diagnostic criteria and stepwise management for immune checkpoint inhibitor myocarditis.

🏆Awards & Recognition 奖项与荣誉

🏆European Society of Cardiology Young Investigator Award

🏆British Cardiovascular Society Research Medal

🏆Imperial College London Excellence in Research Award

📄Data Sources 数据来源

Institution

Last updated: 2026-01-15 | All information from publicly available academic sources

Related Experts 相关专家

Hope S. Rugo

University of California, San Francisco (UCSF)

Antibody-Drug Conjugates in Metastatic Breast CancerASCENT Trial and Sacituzumab Govitecan

Maryam B. Lustberg

Yale School of Medicine / Yale Cancer Center

Cardiotoxicity of CDK4/6 Inhibitors and Endocrine TherapyCancer Treatment-Related Cardiovascular Disease

Sara M. Tolaney

Dana-Farber Cancer Institute / Harvard Medical School

T-DM1 and KATHERINE Trial in Residual Disease After Neoadjuvant TherapyTrastuzumab Deruxtecan (T-DXd) and DESTINY-Breast Trials

Carlos H. Barrios

PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil

CDK4/6 Inhibitors in Low- and Middle-Income Countries (LMIC)Global Breast Cancer Clinical Trials and Access

关注亚历山大·里昂的研究动态

Follow Alexander Lyon's research updates

留下邮箱，当我们发布与 Alexander Lyon（Royal Brompton Hospital, Imperial College London）相关的新研究或访谈时，我们会通知你。

Explore More Experts

Discover the researchers shaping the future of cancer treatment

Browse All Experts Read Research Insights

International Translational Oncology Exchange